| Application no. and date | 13841917.1 (espacenet) (Federated) (European Patent Register), 20130927 | | Patent/reg. no. and date | DK/EP 2900253, 20181114 | | Publication date | 20150805 | | Priority no. and date | US 201261706615 P, 20120927 | | EP pub. no. and date |
EP 2900253 20150805 | | Effective date | | | Applicant/owner | Quincy Bioscience, LLC, 726 Heartland Trail Madison
WI 53717, US | | Applicant ref. no. | 162267 | | Inventor | UNDERWOOD, Mark, Y., 7645 Sawmill Road
Madison, WI 53717, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 38/17 (2006.01) , A61K 38/44 (2006.01) , A61P 25/00 (2006.01) , C12N 9/02 (2006.01) | | Title | FREMGANGSMÅDE TIL LINDRING AF SYMPTOMER PÅ MULTIPLE SCLEROSE BASERET PÅ APOAEQUORIN-HOLDIGE SAMMENSÆTNINGER | | Int. application no. | US2013062268 | | Int. publication no. | WO2014052807 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
